Page last updated: 2024-11-01

omeprazole and Thrombophlebitis

omeprazole has been researched along with Thrombophlebitis in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Thrombophlebitis: Inflammation of a vein associated with a blood clot (THROMBUS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mertens, PR1
Schönfelder, T1
Handt, S1
Kierdorf, H1
Marschall, H1
Busch, N1
Heintz, B1
Sieberth, H1

Other Studies

1 other study available for omeprazole and Thrombophlebitis

ArticleYear
Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion.
    Blood purification, 1998, Volume: 16, Issue:6

    Topics: Acute Kidney Injury; Bile Acids and Salts; Charcoal; Chemical and Drug Induced Liver Injury; Cholest

1998